Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin…
Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable TolerabilityMIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC,…
MUMBAI, India, Feb. 3, 2026 /PRNewswire/ -- Skin Aesthete, the premium dermatology and aesthetics clinic founded by Dr. Sonal Ahuja,…
PARIS, Jan. 22, 2026 /PRNewswire/ -- Faithful to its pioneering spirit since its creation in 1954, Clarins continues its commitment…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…
In Partnership with the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD), CeraVe Mobilizes 9…
SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB…
A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare…
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall…
Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market…